Rates of False-Negative Screening in Prostate Specific Antigen Secondary to 5-Alpha Reductase Inhibitor Usage: A Quality-Improvement Initiative

PURPOSE: Patients often take 5-alpha reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia. However, 5-ARIs can decrease prostate specific antigen (PSA) by approximately half and therefore may lead to false negative PSA tests. We investigated false-screening rates in men o...

Descripción completa

Detalles Bibliográficos
Autores principales: Loloi, Justin, Wei, Matthew, Babar, Mustufa, Zhu, Denzel, Fram, Ethan B., Maria, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306367/
https://www.ncbi.nlm.nih.gov/pubmed/35594325
http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.0099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306367/
https://www.ncbi.nlm.nih.gov/pubmed/35594325
http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.0099

Ejemplares similares